YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
Central Nervous System Neoplasms
Matrix Metalloproteinase 9
In patients with PCNSL, serum levels of YKL-40 and MMP-9 are associated with radiographic disease status. Longitudinal increase in serum levels of YKL-40, but not MMP-9, predicts survival in patients with PCNSL.